1.41% percent quarterly performance for Castle Biosciences Inc (CSTL) is not indicative of the underlying story

On Monday, Castle Biosciences Inc (NASDAQ: CSTL) opened lower -4.14% from the last session, before settling in for the closing price of $20.3. Price fluctuations for CSTL have ranged from $15.45 to $35.84 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Company’s average yearly earnings per share was noted -517.12% at the time writing. With a float of $27.97 million, this company’s outstanding shares have now reached $28.84 million.

The firm has a total of 761 workers. Let’s measure their productivity. In terms of profitability, gross margin is 85.88%, operating margin of -3.97%, and the pretax margin is -0.64%.

Castle Biosciences Inc (CSTL) Insider Activity

A key investor’s attitude towards the stock of the Diagnostics & Research industry is another important factor to consider. The insider ownership of Castle Biosciences Inc is 3.13%, while institutional ownership is 91.54%. The most recent insider transaction that took place on Jun 27 ’25, was worth 357,930. In this transaction Pres. & Chief Exec. Officer of this company sold 17,632 shares at a rate of $20.30, taking the stock ownership to the 3,615 shares. Before that another transaction happened on Jun 27 ’25, when Company’s Pres. & Chief Exec. Officer sold 4,944 for $20.30, making the entire transaction worth $100,363. This insider now owns 69,683 shares in total.

Castle Biosciences Inc (CSTL) Earnings and Forecasts

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.63 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -517.12% per share during the next fiscal year.

Castle Biosciences Inc (NASDAQ: CSTL) Trading Performance Indicators

Check out the current performance indicators for Castle Biosciences Inc (CSTL). In the past quarter, the stock posted a quick ratio of 9.19. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.62. Likewise, its price to free cash flow for the trailing twelve months is 11.60.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.20, a number that is poised to hit -0.51 in the next quarter and is forecasted to reach -1.96 in one year’s time.

Technical Analysis of Castle Biosciences Inc (CSTL)

Analysing the last 5-days average volume posted by the [Castle Biosciences Inc, CSTL], we can find that recorded value of 0.39 million was lower than the volume posted last year of 0.45 million. As of the previous 9 days, the stock’s Stochastic %D was 70.22%.

During the past 100 days, Castle Biosciences Inc’s (CSTL) raw stochastic average was set at 30.78%, which indicates a significant decrease from 57.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 35.93% in the past 14 days, which was lower than the 51.17% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $18.11, while its 200-day Moving Average is $24.79. Now, the first resistance to watch is $20.04. This is followed by the second major resistance level at $20.61. The third major resistance level sits at $20.91. If the price goes on to break the first support level at $19.16, it is likely to go to the next support level at $18.86. Should the price break the second support level, the third support level stands at $18.29.

Castle Biosciences Inc (NASDAQ: CSTL) Key Stats

There are currently 28,872K shares outstanding in the company with a market cap of 561.86 million. Presently, the company’s annual sales total 332,070 K according to its annual income of 18,250 K. Last quarter, the company’s sales amounted to 87,990 K and its income totaled -25,850 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.